Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-06-14 @ 4:20 PM
Study NCT ID:
NCT00954005
Status:
TERMINATED
Last Update Posted:
2015-08-19
First Post:
2009-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma
Sponsor:
German Low Grade Lymphoma Study Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None